Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 31 Nausea 27 Neoplasms 14 Lymphoma, Non-Hodgkin 8 Leukemia, Myeloid, Acute 7 Multiple Myeloma 6 Breast Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma 5 Burkitt Lymphoma 5 Sezary Syndrome 4 Primary Myelofibrosis 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myeloproliferative Disorders 4 Mycosis Fungoides 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia, Hairy Cell 4 Hodgkin Disease 4 Uterine Cervical Neoplasms 3 Pdgfra-Associated Chronic Eosinophilic Leukemia 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Myelodysplastic Syndromes 3 Lymphoma, Large-Cell, Anaplastic 3

Interventions

palbociclib 2 Letrozole 2 Fulvestrant 2 Anastrozole 2 venetoclax 1 pyrotinib 1 pertuzumab 1 penpulimab 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Induction Chemotherapy 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasm Female × Ondansetron × Clear all

NCT03117894 2021-06-04

PECS-2 for Breast Surgery

Umeå University

Phase NA Completed

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡